Searchable abstracts of presentations at key conferences on calcified tissues
Previous issue | Volume 3 | ECTS2014 | Next issue

European Calcified Tissue Society Congress 2014

Prague, Czech Republic
17 May 2014 - 20 May 2014

Card image cap
European Calcified Tissue Society Annual Congress, 17 - 20 May 2014; Prague, Czech Republic

Poster Presentations


Pharmacogenomics of bisphosphonate treatment in Paget's disease of bone: retrospective and prospective analysis
1Department of Medicine, Surgery and Neurosciences University of Siena, Siena, Italy; 2Institute of Genetics and Biophysics - National Research Council of Italy, Naples, Italy; 3Department of Clinical and Experimental Medicine, University of Naples Federico II, Naples, Italy.
A novel mutation in IFITM5, encoding BRIL, impairs osteoblast production of PEDF and causes atypical type VI osteogenesis imperfecta
1Bone and Extracellular Matrix Branch, NICHD/NIH, Bethesda, MD, USA; 2Center for Public Health Genomics and Departments Public Health Sciences, Biochemistry and Molecular Genetics, UVA, Charlottesville, VA, USA; 3Section on Protein Structure and Function, LRCMB, NEI, NIH, Bethesda, MD, USA; 4Shriners Hospital for Children and McGill University, Montreal, Quebec, Canada; 5Department Orthopaedic Surgery, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Correlation of miRNA-mRNA regulatory network profile with bone mass in inbred strains of mice
1Seoul National University College of Medicine, Seoul, Republic of Korea; 2Konkuk University Hospital, Seoul, Republic of Korea; 3Chungbuk National University Hospital, Cheongju, Republic of Korea.
Premature aging of bone is delayed by dietary restriction
1Internal medicine, Erasmus MC, Rotterdam, The Netherlands; 2Orthopedic Research, Balgrist University Hospital, Zurich, Switzerland; 3National Institute of Public Health, Bilthoven, The Netherlands; 4Genetics, Erasmus MC, Rotterdam, The Netherlands.
Functional analysis of a promoter polymorphism of optineurin, a gene associated to Paget's disease of bone
1PhD program, PhD Program in Biomedical Sciences, Department of Biomedical Sciences and Medicine, University of Algarve, Faro, Portugal; 2Centre of Marine Sciences (CCMAR), University of Algarve, Faro, Portugal; 3Medicine Department, Université Laval and Centre de Recherche du CHU de Québec, Quebec, Canada; 4Department of Biomedical Sciences and Medicine, University of Algarve, Faro, Portugal.
Genetic determinants of bone mineral density loss in aromatase inhibitors treatment in the B-ABLE Cohort
1IMIM (Hospital del Mar Medical Research Institute), Red Temática de Investigación Cooperativa en Envejecimiento y Fragilidad (RETICEF), Instituto de Salud Carlos III FEDER, Barcelona, Spain; 2Internal Medicine Department, Universitat Autònoma de Barcelona, Barcelona, Spain; 3Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Oxford NIHR Musculoskeletal Biomedical Research Unit, University of Oxford, Oxford, UK; 4Medical Oncology Department, IMIM (Hospital del Mar Research Institute), Barcelona, Spain; 5Departament de Genètica, Universitat de Barcelona, IBUB, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), ISCIII, Barcelona, Spain.
MK-7 enhances expression of genes related to bone, enamel and dentin, and reduces the expression of genes related to apoptosis in developing murine molars
1Department of Oral Biology, Faculty of Dentistry, University of Oslo, Oslo, Norway; 2University of Oslo, Faculty of Dentistry, Institute for Clinical Odontology, Oral Research Laboratory, Oslo, Norway.
Analysis of genetic polymorphisms in relation to bone mineral density and fracture risk in maltese postmenopausal women
Department of Applied Biomedical Science, Faculty of Health Sciences, University of Malta, Msida, Malta.